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Background: Hospitalizations for persons with chronic obstructive pulmonary disease (COPD) 
result in significant health care resource use and excess expenditures. Despite well-documented 
sociodemographic disparities in COPD outcomes, no study has characterized geographic varia-
tions in COPD hospitalization across the US.
Methods: Almost 3.8 million COPD hospitalization records were extracted from Medicare 
claims for 1995–2006, and the total population of eligible Medicare beneficiaries was extracted 
from the Medicare enrollment records to calculate COPD hospitalization rates by Health Service 
Area (HSA), (n = 949). Spatial cluster analysis and Bayesian hierarchical spatial modeling were 
used to characterize the geography of COPD hospitalizations.
Results: The overall COPD hospitalization rate was 11.30 per 1,000 beneficiaries for the 
aggregated period 1995–2006. HSA-level COPD hospitalization rates had a median of 11.7 and 
a range of 3.0 (Cache, UT) to 76.3 (Pike, KY). Excessive hospitalization risk was concentrated 
in Appalachia, the southern Great Lakes, the Mississippi Delta, the Deep South, and west Texas. 
In the Bayesian spatial mixture model, 73% of variability of COPD hospitalization relative risk 
was attributed to unidentified regional social and physical environments shared by HSAs rather 
than to unique local HSA factors (27%).
Conclusion: We discovered distinct geographic patterns in COPD hospitalization rates and risks 
attributed to both regionally-shared environmental risk factors and HSA-unique environmental 
contexts. The correlates of these geographic patterns remain to be determined. Geographic 
comparisons of COPD hospitalization risk provide insights for better public health practice, 
policies, and programs for COPD prevention.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a heterogeneous group of slowly 
progressive diseases characterized by airflow limitation and gradual loss of lung function 
that is not fully reversible.1 COPD represents 5% of total deaths and is the fourth lead-
ing cause of death in the US. The absolute number of deaths from COPD increased 8% 
from 116,494 in 2000 to 126,005 in 2005.2 During 1980–2000, the overall death rate for 
COPD increased 67%.3 The COPD average attributable excess health care expenditures 
are nearly US$6,300 per Medicare patient.4 The annual number of inpatient days for 
COPD (8.18 days) is only second to chronic kidney disease (9.51 days).5 COPD is highly 
prevalent and associated with comorbid disease and physical dysfunction.6
Significant sociodemographic disparities in COPD outcomes have been reported 
for the US. Only a few studies explored their geographic variations.7–10 A broader International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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view of the causes of population health disparities including 
race, ethnicity, socioeconomic status, and geography is 
necessary for better solutions to complex population health 
problems.11 Understanding geographic variations in COPD 
hospitalization could help public health policy makers more 
clearly identify target areas with great needs and facilitate 
the formulation of better solutions to improve COPD pre-
vention and treatment. No previous study has characterized 
the geographic variations in COPD hospitalization across 
the US. This study examined geographic disparities in COPD 
hospitalization of Medicare beneficiaries in the US, at the 
state and Health Service Area (HSA) level. The geographic 
variations in regionalized and local environmental factors 
that contributed to excessive HSA hospitalization risk were 
then assessed.
Methodology
Data
COPD hospitalization data were extracted from 100% of 
the Part A Medicare claims for 1995–2006. The number of 
Medicare hospitalizations for which COPD was the primary 
discharge diagnosis using International Classification of 
Diseases, Ninth Revision (ICD-9) codes 490 (bronchitis 
not specified as acute or chronic), 491 (chronic bronchitis), 
492 (emphysema), and 496 (chronic airway obstruction, not 
elsewhere classified) were obtained. Medicare enrollment 
records were used as the denominator file to calculate the 
total population of eligible Medicare beneficiaries (limited 
to those aged 65 and older in fee-for-service Medicare) for 
each HSA (n = 949).
The outcome measure is the COPD Medicare beneficiary 
hospitalization rate over a 12-year study period (1995–2006) 
by HSA (we chose to use the National Cancer Institute’s 
modified HSAs to ensure that all HSAs were fully contained 
within discrete states and that no state boundary crossings 
occurred, as is the case with the original HSAs defined by the 
National Center for Health Statistics). HSAs were selected 
as the geographic units of analysis for three main reasons. 
First, smaller geographic units (eg, counties) would have 
small numbers of Medicare hospitalizations and enrollee 
populations, which yield statistically unstable estimates of 
COPD hospitalization rates. Second, HSAs were designated 
for effective planning and development of health services. 
Similar healthcare resource delivery patterns within a HSA 
may be relevant to its residents’ COPD hospitalization health-
care needs. Finally, state level aggregations would smooth 
out significant sub-state variations of COPD hospitalization. 
The 12-year temporal aggregation resulted in a minimum 
of 8 COPD hospitalizations and a Medicare population of 
at least 1,235 for all 949 HSAs, which provides a base for 
reliable estimation of HSA-level COPD hospitalization rates 
and risk.
statistical analysis and modeling
The preliminary descriptive analysis included crude rates 
and maps. Statistical analysis began with spatial cluster 
analysis to explore spatial continuities and discontinuities of 
COPD hospitalization rates. Spatial continuities (or discon-
tinuities) indicate that COPD hospitalization rates and risk 
exhibit smooth (or disruptive) variation between adjacent 
geographic areas. Namely the rate or risk surface of COPD 
hospitalization has a smooth (or discordant) spatial pattern 
among neighboring areas. These smooth or discordant pat-
terns could be attributable to a number of as yet undefined 
factors. A Bayesian hierarchical spatial modeling approach 
was applied to characterize the geography of COPD hos-
pitalization risk. The goal was to identify which HSAs or 
regions have significantly higher or lower COPD hospital-
ization risks compared to the average HSA level risk, and 
whether HSA local or regional characteristics, or both, may 
contribute to HSAs’ excessive or reduced COPD hospitaliza-
tion risks. Regional characteristics are those environmental/
contextual conditions that extend over a large area, perhaps 
encompassing several states (eg, Appalachia) – these may 
represent widespread spatial processes, such as regionalized 
poverty. HSA local characteristics represent environmental/
contextual conditions that occur in smaller areas (eg, one or a 
few contiguous counties) – these may represent place-specific 
conditions, such as localized occupational exposures.
State and HSA level COPD hospitalization rate maps 
(Figures 1 and 2) showed large geographic variations and 
strong spatial continuities and some discontinuities over 
the US. Using STIS software (TerraSeer, Inc), the Moran I 
index12 was computed to assess the overall spatial autocor-
relation of HSA COPD hospitalization rates across the US, 
while local indicators of spatial association13 were computed 
to examine their local spatial dependence and   discontinuities. 
Local spatial cluster analysis classified HSAs into the follow-
ing five categories: 1) spatial clusters of HSAs with signifi-
cantly higher rates than surrounding HSAs; 2) spatial clusters 
of HSAs with significantly lower rates than the surrounding 
HSAs; 3) spatial outliers of HSAs with significantly higher 
rates than surrounding HSAs; 4) spatial outliers of HSAs 
with significantly lower rates than surrounding HSAs; and 
5) HSAs that have no significant spatial autocorrelation with 
surrounding HSAs for COPD hospitalization rates.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Figure 1 COPD hospitalization rate (per 1,000 enrollees) among Medicare beneficiaries by state (1995–2006).
Bayesian hierarchical spatial modeling is commonly 
used in disease mapping and small area risk assessment.14 
A Bayesian spatial mixture model15 was constructed, which 
extends the classical spatial convolution model16 by intro-
ducing a spatial mixture parameter to balance the spatially 
smooth and disruptive effects on COPD outcomes. The 
spatial mixture model was implemented via Markov Chain 
Monte Carlo methods in WinBUGS.17
Results
Descriptive analysis
There was a total of 3,786,908 Medicare beneficiaries hos-
pitalized with COPD in the US between 1995 and 2006, 
(mean = 315,576/year). The 1995–2006 average COPD 
hospitalization rate was 11.30 per 1,000 Medicare benefi-
ciaries (Table 1). The annual rates exhibited no significant 
temporal trend; the rate increased from 10.46 per 1,000 in 
1995 to 13.38 per 1,000 in 1999 and then decreased to 10.21 
per 1,000 in 2006. However, there were significant differences 
among states and HSAs. At state level, Utah (3.6 per 1,000) 
and Hawaii (4.5 per 1,000) had the lowest rates, while West 
Virginia (23.7 per 1,000) and Kentucky (20.8 per 1,000) had 
the highest rates (Figure 1). Large portions of the Mississippi 
Delta, the Deep South, and Appalachia formed a large geo-
graphic cluster with significantly higher rates, while northern 
and western states had lower rates.
COPD hospitalization rates had larger geographic varia-
tions in HSAs than in states, with a median of 11.7 per 1,000 
and a range of 3.0 per 1,000 (Cache, UT) to 76.3 per 1,000 
(Pike, KY) (Figure 2). Wide contrasts between the state 
rate and a 2 to 3 times higher HSA rate occurred in West 
Virginia, North Dakota, Kentucky, Oklahoma, Arkansas, 
and Virginia. In contrast, some HSAs in Minnesota, Idaho, 
Iowa, Nebraska, Mississippi, Kansas, and Montana had rates 
that were less than half of the rates of their respective states. 
The five states with the largest percentage point range in 
intrastate HSA-specific rates were Kentucky (64.49), West 
Virginia (55.69), Virginia (51.87), Arkansas (40.30), and 
Oklahoma (35.74). The five states with the smallest percent-
age point range in HSA-specific rates were Rhode Island 
(1.28), Delaware (1.68), New Jersey (3.23), Nevada (3.80), 
and Connecticut (4.42). With few exceptions, states with 
the highest and lowest ranges of intrastate rates were highly 
clustered geographically.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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spatial analysis
Moran’s I for HSA COPD hospitalization rates (1995–2006) 
had a value of 0.59 (P , 0.0001), confirming a significant 
positive spatial autocorrelation at the HSA level for COPD 
hospitalization rates across the US. Local spatial cluster 
analysis identified 35 HSAs within spatial clusters of 
high rates, 163 HSAs within spatial clusters of low rates, 
2 high-rate spatial outliers (Beltrami-Clearwater HSA in 
Minnesota and Alpine HSA in California), and 1 low-rate 
spatial outlier (Greenbrier-Monroe HSA in West Virginia). 
Spatial clusters of high rates were concentrated in central 
Appalachia and northeast Arkansas. Spatial clusters of low 
rates were located in broad areas of the upper Midwest and 
central Great Plains, the Rocky Mountains and Great Basin, 
the Pacific Northwest, and California.
The Bayesian spatial mixture model showed that nearly 
73% variability of the COPD hospitalization relative risk 
was attributed to the spatially structured effects. Thus, the 
HSAs’ regionalized social and physical environments have 
a greater influence on COPD hospitalization than the HSAs’ 
local environmental risk factors. This finding is consistent 
with the strong positive spatial autocorrelation from spatial 
cluster analysis. These social and physical environments have 
not yet been identified in the current report.
geography of COPD hospitalization risk
The geography of excessive or reduced risk for COPD 
hospitalization was estimated using the posterior probability 
Hospitalization rate (per 1,000)
3.0–8.0
8.1–10.5
10.6–12.9
13.0–16.2
16.3–76.3
Figure 2 COPD hospitalization rate (per 1,000 enrollees) among Medicare beneficiaries by HSA (1995–2006).
Table 1 Medicare beneficiary COPD hospitalizations rates (per 
1,000 enrollees) by year
Year Medicare  
population
COPD  
hospitalization
Rate  
(per 1000)
1995 28,584,063 299,112 10.46
1996 28,052,524 304,218 10.84
1997 27,289,171 320,298 11.74
1998 26,525,251 321,774 12.13
1999 26,198,615 350,659 13.38
2000 26,564,681 318,740 12.00
2001 27,378,646 322,811 11.79
2002 28,191,343 326,379 11.58
2003 28,704,729 317,275 11.05
2004 29,059,259 290,993 10.01
2005 29,160,779 313,635 10.76
2006 29,483,742 301,014 10.21
Overall 335,192,803 3,786,908 11.30International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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from the Bayesian spatial mixture model. The relative risks 
attributable to undefined regional and local environmental 
influences were mapped in Figures 3 and 4 respectively. 
A large, contiguous area of 377 HSAs with significant spa-
tially structured excessive risk (probability exceeding 0.8) 
was concentrated in Appalachia, the southern Great Lakes 
states, the Mississippi Delta, the Deep South, and west Texas. 
By contrast, 38 HSAs with significant unstructured local 
excessive risk (probability exceeding 0.8) were sparsely 
spread over the northern Great Plains and along the East 
Coast. Reduced hospitalization risks due to regional envi-
ronmental factors were observed in 355 HSAs mainly in the 
western US, while 59 HSAs in the eastern and south central 
US had reduced hospitalization risks that were potentially 
associated with local unique environment factors.
Discussion
Medicare claims data were used to characterize substantial 
geographic variations in COPD hospitalization risk among 
states (Figure 1) and HSAs (Figure 2) for individuals aged 65 
and older in fee-for-service Medicare. The HSA-level analysis 
highlights high hospitalization burdens within states whose 
overall rates may not be high relative to other states. This 
geographic analysis facilitates identification of target areas 
of high need, leading to more efficient and effective use of 
resources. There were distinct geographic patterns in COPD 
hospitalization risks attributed to regionally-shared environ-
mental risk factors (Figure 3) and HSA-unique environmental 
contexts (Figure 4). These undefined environmental risk factors 
for HSA COPD hospitalization are strongly spatially correlated 
among those neighboring HSAs, while a few HSAs could 
attribute their COPD hospitalization risk to their unique local 
environmental context. These findings suggest that two spatial 
processes may be operating with respect to environmental 
influences on COPD hospitalization; first, broad regionalized 
contextual effects (eg, socioeconomic factors and high region-
alized population smoking rates) may be exacerbating COPD 
hospitalizations. Second, localized environmental factors, 
such as occupational exposures, may be influencing COPD 
hospitalizations. Further studies are needed to understand these 
specific regional and local environmental factors contributing 
to excess or reduced COPD hospitalization risk.
Probability that relative risk is >1
<0.2 (355)
0.2–0.8 (210)
> = 0.8 (377)
No data
Figure 3 COPD hospitalization relative risk exceeding 1, attributable to regional environmental factors.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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This analysis yields valuable insights into the potential 
ecological factors that could explain geographic variations 
in COPD. In turn, this could help to generate hypotheses for 
further research. For example, the large area of increased 
hospitalization risk due to regionalized factors (Figure 3) 
might suggest the inclusion of a socioeconomic status vari-
able such as poverty, as an area-level covariate in further 
models. In contrast, areas with increased hospitalization risk 
due to localized factors (for example, many of the HSAs 
in the western US, shown in Figure 4) might suggest the 
inclusion of area-level covariates such as the percentage of 
the population employed in mining or agriculture, in which 
occupational exposures have been hypothesized to exacerbate 
COPD, thus leading to higher hospitalization rates.
The drivers of these significant geographic disparities 
is far from simple, because COPD hospitalization does not 
only reflect medical care, because also the severity of the 
COPD and other co-existing chronic conditions.5 There is 
evidence to suggest that the geographic disparities in COPD 
hospitalization could be explained mainly by classical risk 
factors such as smoking, a well-documented individual 
risk factor for COPD mortality and morbidity.18 However 
there exists a significant temporal and spatial mismatch 
between population smoking and COPD hospitalization 
rates. If smoking is a dominant contributor of COPD 
hospitalization, one would expect to observe a significant 
decreasing COPD hospitalization rate in the US. Also, from 
the geographic perspective, western states (eg, North Dakota, 
Montana, and Wyoming) have relative high smoking rates19 
but low COPD hospitalization rates. Yet, high smoking 
prevalence is consistent with high COPD hospitalization 
rates in Appalachian areas and neighboring regions. This 
geographic match and mismatch between population 
smoking prevalence and COPD hospitalization rates suggests 
that environment risk factors may have geographically 
differential relationships with COPD hospitalization risk. 
Population smoking could be a major contributor of COPD 
hospitalization in some areas while other environmental 
risk factors, such as air pollution (indoor and outside)20–22 
and occupational exposures (mining, farming, and 
construction)23–27 or exposure to biomass heating fuel,20,28,29 
could play a dominant role in other areas.
No data
<0.2 (59)
0.2–0.8 (845)
> = 0.8 (38)
Probability that relative risk is >1
Figure 4 COPD hospitalization relative risk exceeding 1, attributable to local environment factors.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Brown describes significant state-level geographic 
  variations in COPD mortality.7 A state-level comparison 
between COPD hospitalization and mortality rates shows 
significant geographic matches and mismatches across the 
US. This again indicates that these two COPD outcomes share 
some commonalities in their risk factors but also have differ-
ences in their potential sets of risk factors. A further Bayesian 
spatial mixture model with both COPD outcomes (hospital-
ization and mortality) at the same time may disentangle the 
potential factors behind their geographic patterns.
There are a few limitations of this study. First, the study 
population includes only those individuals age 65 and older 
who are enrolled in fee-for-service Medicare. It does not 
include younger individuals or those who are receiving care 
funded through private savings or other insurance. Having 
data on these populations would help to better understand 
COPD hospitalization patterns and factors that could poten-
tially explain geographic variations.
Second, this is an ecological study with potential for 
ecological fallacy or bias. Observed geographic variations 
in COPD hospitalization might be a consequence of the dif-
ferent demographic composition in Medicare enrollees. For 
example, COPD is the third leading cause of mortality for 
the age group 65–84 and fourth leading cause for the age 
group of 85 and above.30 Geographic variations in COPD 
hospitalization should be affected by regional elderly popula-
tion compositions. However, because Medicare Claims data 
does not provide accurate measures of individual risk factors, 
such as smoking and occupation exposure, ecological studies 
provide a viable framework to evaluate the environmental 
exposures on COPD hospitalization.
Third, geographic differences in COPD hospitalization 
may change over time. This study was based on aggregated 
12-year Medicare claims data; therefore it was not possible 
to determine whether the spatial pattern of COPD hospital-
ization is stable over the study period. Further research is 
needed to examine the spatiotemporal changes in COPD 
hospitalization to confirm the implicit assumption of its stable 
spatial configuration.
COPD is a chronic disease that can be prevented and 
treated. COPD hospitalization is a costly and sometimes 
life-threatening event associated with a variety of environ-
mental risk factors, including access to health care.1,31–34 The 
geographic variation of COPD hospitalization highlights 
the potential and possibility of reducing its geographic 
disparities. From population health policy, the observed 
geographic gaps in COPD hospitalization risk could be the 
consequence of different regional   environmental exposures, 
but it may be more a result of different COPD community 
prevention efforts. The variation among states in COPD 
hospitalization suggests reducing COPD hospitalization 
burden may be possible on a national scale; although this 
study did not investigate the exact environmental expo-
sures or community healthcare practices that cause these 
differences. The differences in COPD hospitalization 
rates among states and among HSAs further pinpoints the 
potential local areas which could benefit from enhanced 
public health efforts to prevent and reduce COPD hos-
pitalization, even among those states with overall lower 
COPD hospitalization rates. Geographic comparison of 
lower and higher regional COPD hospitalization risk could 
also provide insights for better public health practice for 
COPD prevention. This study focused on the geography 
of COPD hospitalization burden and risk in order to facili-
tate public health policy delivery for COPD prevention 
and to improve public health practice strategies to reduce 
COPD hospitalization. Future studies could examine the 
impact of programs such as the National Heart, Lung, and 
Blood Institute’s (NHLBI) “Learn More Breathe Better” 
campaign. The NHLBI campaign is focused in the US and 
seeks to develop better public health policies and strategies 
in partnership with primary care providers, public health 
professionals, and persons with or at risk for COPD to 
reduce the morbidity and mortality burden associated with 
COPD by increasing awareness and promoting effective 
prevention and treatment strategies.
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